Kazia Therapeutics (KZIA) Retained Earnings (2017 - 2025)

Kazia Therapeutics' Retained Earnings history spans 6 years, with the latest figure at $2.0 million for Q2 2025.

  • For Q2 2025, Retained Earnings fell 13.31% year-over-year to $2.0 million; the TTM value through Jun 2025 reached $2.0 million, down 13.31%, while the annual FY2025 figure was $2.0 million, 13.31% down from the prior year.
  • Retained Earnings reached $2.0 million in Q2 2025 per KZIA's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $2.5 million in Q2 2023 to a low of $1.7 million in Q2 2022.
  • Average Retained Earnings over 4 years is $2.1 million, with a median of $2.1 million recorded in 2024.
  • Peak YoY movement for Retained Earnings: soared 42.4% in 2023, then decreased 13.31% in 2025.
  • A 4-year view of Retained Earnings shows it stood at $1.7 million in 2022, then skyrocketed by 42.4% to $2.5 million in 2023, then dropped by 6.91% to $2.3 million in 2024, then dropped by 13.31% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Retained Earnings are $2.0 million (Q2 2025), $2.3 million (Q2 2024), and $2.5 million (Q2 2023).